Accretion Nutraveda Subscription
Last updated on 29-Jan-2026 16:56:05
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 364000 | 362000 | 0.99 |
| HNIs | 276000 | 178000 | 0.64 |
| bHNI | 184000 | 88000 | 0.48 |
| sHNI | 92000 | 90000 | 0.98 |
| Individual | 640000 | 274000 | 0.43 |
| Total | 1280000 | 814000 | 0.64 |
Application-Wise Breakup  | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 61 | 12 | 0.2 |
| HNIs (3-10L) | 31 | 24 | 0.77 |
| Individual | 320 | 137 | 0.43 |
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹0.2 | @8% ₹0.2 | @9% ₹0.2 | @10% ₹0.2 | @11% ₹0.3 | @12% ₹0.3 |
Accretion Nutraveda Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 2000 | 258000 | 320 |
| sHNI | 3 | 3000 | 387000 | 31 |
| bHNI | 8 | 8000 | 1032000 | 61 |
Accretion Nutraveda Reservation
| Category | Shares Offered | % |
|---|---|---|
| Anchor | 544000 | 28.33% |
| QIB | 364000 | 18.96% |
| HNI | 276000 | 14.38% |
| INDIVIDUAL | 640000 | 33.33% |
| Market Maker | 96000 | 5% |
| Total | 1920000 | 100% |
Accretion Nutraveda About
IPO Details
| Total Issue Size | 19,20,000 shares (aggregating up to ₹24.77 Cr) |
| Fresh Issue | 19,20,000 shares (aggregating up to ₹24.77 Cr) |
| Face Value | ₹10/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 53,20,000 Equity Shares |
| Share Holding Post Issue | 72,40,000 Equity Shares |
| Reserved for Market Maker | 96,000 shares (aggregating up to ₹1.23 Cr) |
| Market Maker | Sunflower Broking Private Limited |
Key Performance Indicators (KPI)
| KPI | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| ROE | 68.54% | 81.22% | 121.94% |
| ROCE | 49.09% | 36.98% | 28.98% |
| EPS (BASIC) | 4.73 | 7.19 | 2.28 |
| P/E Pre IPO | 26.27 | ||
| P/E Post IPO | 20.02 |
Company Financial (In ₹Crore)
| Period Ended | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 16.35 | 10.86 | 4.64 | 4.06 |
| Total Income | 14.07 | 16.06 | 5.2 | 3.07 |
| Profit After Tax | 2.33 | 2.61 | 0.82 | 0.28 |
| EBITDA | 3.29 | 3.65 | 1.21 | 0.59 |
| NET Worth | 8.26 | 5.35 | 1.08 | 0.26 |
| Reserves and Surplus | 2.95 | 4.86 | 0.72 | -0.1 |
| Total Borrowing | 4.43 | 3.86 | 2.17 | 1.97 |
Peer Comparision (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value (₹) |
|---|---|---|---|
| Accretion Nutraveda | 26.27 | 129.00 | 10.00 |
| Walpar Nutritions | 3.3 | 45.90 | 10.00 |
| Influx Healthtech | 46.99 | 226.00 | 10.00 |
Peer Comparision (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| Accretion Nutraveda | 16.74 | 56.5 | 4.73 |
| Walpar Nutritions | 17.05 | 6.24 | 1.06 |
| Influx Healthtech | 38.98 | 11.1 | 4.81 |
About Company
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and nutraceutical products across multiple dosage forms, including tablets, capsules, liquids, powders, oils, balms, creams, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO), catering to both domestic and international markets, including Sri Lanka, Singapore, and the USA.
Its product offerings integrate classical Ayurvedic formulations with modern nutraceutical science, addressing health segments such as liver care, women’s health, bone & joint health, cognitive wellness, and respiratory care.
Business operations are spread across two verticals:
Domestic sales & merchant exports (loan license basis) – contributing 96.62% of revenue in FY25
Direct exports – contributing 38%, reflecting strong export traction
The company operates a 10,763 sq. ft. manufacturing facility in Gujarat, equipped with 13 air handling units, segregated processing areas, and quality control systems.
The facility holds multiple certifications, including GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, Halal, and FSSAI license.
IPO proceeds are proposed to be utilised for automation and expansion of manufacturing facilities, working capital requirements, and general corporate purposes.
Strength
Experienced promoters and management team with domain knowledge in Ayurvedic and nutraceutical manufacturing.
Diverse product portfolio spanning multiple therapeutic and wellness segments.
Strong focus on quality and compliance, supported by multiple global certifications.
Weakness
Manufacturing operational risks, including equipment failure, accidents, or natural disruptions affecting production.
Regulatory and compliance risks, due to past discrepancies in statutory filings and records.
Customer concentration risk, as the company depends on a limited number of customers for a significant portion of revenue.
Accretion Nutraveda Lead Manager(s)
Accretion Nutraveda Address
Address
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
+91- 9904366177
E-Mail: compliance@accretionnutraveda.com
Website: https://accretionnutraveda.com/